Literature DB >> 23267306

Otomycosis with Perforated Tympanic Membrane: Self medication with Topical Antifungal Solution versus Medicated Ear Wick.

A S Abou-Halawa1, M A Khan, A A Alrobaee, A A Alzolibani, H A Alshobaili.   

Abstract

OBJECTIVES: In otomycosis with tympanic membrane perforation, many physicians prefer to insert an ear wick medicated with antimycotic cream. This needs multiple visits to the clinic and keeps the ear blocked for several days. Direct instillation of alcohol based antimycotic solution causes severe burning if it reaches the middle ear. In this work we compare patient's self medication with clotrimazole antimycotic solution used on Q-tips with physician-inserted ear wicks; in terms of safety, efficacy and patient satisfaction. STUDY DESIGN #ENTITYSTARTX00026;
SETTING: Prospective controlled study in ambulatory setting.
METHODOLOGY: Forty consecutive patients with otomycosis with tympanic membrane perforation were included in the study. Diagnosis of otomycosis was both clinical and with mycological culture. Mean pure tone average (PTA) in the involved ear was measured after cleaning fungal debris. Patients were then, randomized into two groups; Q-tip group patients (n=20) were taught to self-medicate their ears two times daily with the clotrimazole solution on suitable Q-tips for three weeks. In ear wick group (n=20), a gauze wick impregnated with clotrimazole cream was inserted in the ear. Wick was changed every third day for two more visits (one week overall). Patients were followed up for 3 months.
RESULTS: After three weeks all patients in Q-tip group and ear wick group had relief of their ear itching and complete disappearance of fungal growth in the deep meatus and on the tympanic membrane. PTA was 22 ± 11dB in Q-tip group and 25 ± 12 dB in ear wick group; the difference was not statistically significant (p= 0.11). Patients in ear wick group had sense of ear blocking and wetness during period of treatment. Transient burning sensation was reported by 2 patients in Q-tip group. During three months, there was recurrence of otomycosis in 5 patients from ear wick group and no recurrence in Q-tip group (p=0.04).
CONCLUSION: Self medication with clotrimazole solution on Q-tips and physician inserted medicated wicks are equally safe in treating otomycosis with perforated tympanic membrane. However, self medication with antimycotic solution on Q-tips gives more patient satisfaction and less rate of otomycosis recurrence.

Entities:  

Keywords:  clotrimazole; ear external; topical; tympanic membrane perforation

Year:  2012        PMID: 23267306      PMCID: PMC3523785          DOI: 10.12816/0005975

Source DB:  PubMed          Journal:  Int J Health Sci (Qassim)        ISSN: 1658-3639


  18 in total

1.  Attitude of self ear cleaning in black Africans: any benefit?

Authors:  Abdulrahmnan O Afolabi; Aliyu M Kodiya; Aminu Bakari; Babagana M Ahmad
Journal:  East Afr J Public Health       Date:  2009-04

Review 2.  [Antimycotic therapy in otomycosis with tympanic membrane perforation].

Authors:  G Dyckhoff; T Hoppe-Tichy; R Kappe; A Dietz
Journal:  HNO       Date:  2000-01       Impact factor: 1.284

3.  Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians.

Authors:  A B Fleischer; S R Feldman
Journal:  Clin Ther       Date:  1999-10       Impact factor: 3.393

Review 4.  In vitro effectiveness of 13 agents in otomycosis and review of the literature.

Authors:  J C Stern; M K Shah; F E Lucente
Journal:  Laryngoscope       Date:  1988-11       Impact factor: 3.325

5.  Otomycosis--a clinico-mycological study and efficacy of mercurochrome in its treatment.

Authors:  J Chander; S Maini; S Subrahmanyan; A Handa
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

6.  Otomycosis in Shanghai: aetiology, clinical features and therapy.

Authors:  Xianhao Jia; Qin Liang; Fanglu Chi; Wenjun Cao
Journal:  Mycoses       Date:  2011-10-17       Impact factor: 4.377

7.  Ototoxicity of common topical antimycotic preparations.

Authors:  L W Tom
Journal:  Laryngoscope       Date:  2000-04       Impact factor: 3.325

8.  Otomycosis: clinical features and treatment implications.

Authors:  Tang Ho; Jeffrey T Vrabec; Donald Yoo; Newton J Coker
Journal:  Otolaryngol Head Neck Surg       Date:  2006-11       Impact factor: 3.497

9.  Mycotic infection of the ear (otomycosis): a prospective study.

Authors:  K O Paulose; S Al Khalifa; P Shenoy; R K Sharma
Journal:  J Laryngol Otol       Date:  1989-01       Impact factor: 1.469

10.  In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.

Authors:  Ayse Demet Kaya; Nuri Kiraz
Journal:  Mycoses       Date:  2007-11       Impact factor: 4.377

View more
  5 in total

1.  Single Dose Topical Application of Clotrimazole for the Treatment of Otomycosis: Is This Enough?

Authors:  Rıza Dundar; İsmail İynen
Journal:  J Audiol Otol       Date:  2018-12-07

2.  Primary otomycosis in the Indian subcontinent: predisposing factors, microbiology, and classification.

Authors:  Sampath Chandra Prasad; Subbannayya Kotigadde; Manisha Shekhar; Nikhil Dinaker Thada; Prashanth Prabhu; Tina D' Souza; Kishore Chandra Prasad
Journal:  Int J Microbiol       Date:  2014-05-18

3.  Assessment of Response to Treatment in Patients with Otomycosis.

Authors:  Keyvan Kiakojori; Nasim Bagherpour Jamnani; Soraya Khafri; Saeid Mahdavi Omran
Journal:  Iran J Otorhinolaryngol       Date:  2018-01

4.  Effect of combination therapy with ceftizoxime and clotrimazole in the treatment of otomycosis.

Authors:  Saeid Mahdavi Omran; Zahra Yousefzade; Soraya Khafri; Mojtaba Taghizadeh-Armaki; Keyvan Kiakojuri
Journal:  Curr Med Mycol       Date:  2018-03

5.  Role of Clotrimazole in Prevention of Recurrent Otomycosis.

Authors:  Keyvan Kiakojuri; Ramazan Rajabnia; Saeid Mahdavi Omran; Abazar Pournajaf; Mohsen Karami; Mojtaba Taghizadeh Armaki
Journal:  Biomed Res Int       Date:  2019-12-26       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.